Citi raises Protagonist Therapeutics price target to $182

September 1, 2026 4:07 AM

Citi analyst Geoff Meacham raised his price target on Protagonist Therapeutics (NASDAQ: PTGX) to $182 from $175, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found